Vertex Pharmaceuticals (VRTX) Short-Term Debt issuances (2017)

Vertex Pharmaceuticals' Short-Term Debt issuances history runs 1 years deep, the most recent figure standing at $300.0 million for Q1 2017.

• In Q1 2017, Short-Term Debt issuances changed N/A year-over-year to $300.0 million; the TTM figure through Dec 2017 stood at $300.0 million (changed N/A YoY), while the FY2017 annual figure was $300.0 million, changed N/A from the prior year.
• Short-Term Debt issuances for Q1 2017 stood at $300.0 million.
• The five-year high for Short-Term Debt issuances was $300.0 million in Q1 2017, with the low at $300.0 million in Q1 2017.